Virtus ETF Advisers LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 60 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$91,000
-48.3%
44,300
-5.6%
0.04%
-37.9%
Q4 2021$176,000
-28.2%
46,931
-0.9%
0.07%
-38.9%
Q3 2021$245,000
+15.6%
47,350
-5.0%
0.11%
+24.1%
Q2 2021$212,000
-45.5%
49,819
-32.0%
0.09%
-47.0%
Q1 2021$389,000
+0.3%
73,237
+1.8%
0.16%
+1.9%
Q4 2020$388,000
+57.1%
71,954
+132.0%
0.16%
+23.8%
Q3 2020$247,000
-30.0%
31,009
-12.0%
0.13%
-22.2%
Q2 2020$353,000
+61.9%
35,241
-30.4%
0.17%
-64.0%
Q1 2019$218,000
-34.9%
50,655
-13.0%
0.46%
+714.0%
Q4 2018$335,000
-34.3%
58,223
+54.8%
0.06%
+7.5%
Q3 2018$510,000
-34.1%
37,603
-42.3%
0.05%
-92.3%
Q2 2018$774,000
+307.4%
65,221
+141.8%
0.68%
+643.5%
Q3 2016$190,000
-13.6%
26,9740.0%0.09%
-43.6%
Q2 2016$220,000
-3.9%
26,974
-4.3%
0.16%
-48.3%
Q1 2016$229,00028,1820.32%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 38,974,185$166,030,0001.81%
Endurant Capital Management LP 1,539,435$6,558,0001.80%
NEA Management Company, LLC 17,082,611$72,772,0000.95%
PFM Health Sciences, LP 3,627,900$15,455,0000.48%
GSA CAPITAL PARTNERS LLP 513,388$2,187,0000.25%
Baker Brothers Advisors 9,830,877$41,880,0000.18%
Avoro Capital Advisors LLC 2,024,400$8,624,0000.15%
Vigilare Wealth Management 54,250$231,0000.14%
AlphaCentric Advisors LLC 120,000$511,0000.14%
Rock Springs Capital Management LP 1,545,000$6,582,0000.13%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders